C12N 2310/3517
Marker
Official title: Marker; Tag
C12N2310/3517 (Marker) appears on 298 US grants and 509 published applications in this corpus.
Search patents in C12N- Granted patents
- 298
- Published applications
- 509
- Assignees
- 316
- Inventors
- 1,033
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 1 |
| 2002 | 6 | 4 |
| 2003 | 1 | 20 |
| 2004 | 3 | 10 |
| 2005 | 1 | 10 |
| 2006 | 1 | 15 |
| 2007 | 1 | 4 |
| 2008 | 2 | 6 |
| 2009 | 3 | 14 |
| 2010 | 5 | 12 |
| 2011 | 6 | 15 |
| 2012 | 4 | 11 |
| 2013 | 20 | 12 |
| 2014 | 0 | 16 |
| 2015 | 13 | 23 |
| 2016 | 9 | 20 |
| 2017 | 19 | 27 |
| 2018 | 18 | 39 |
| 2019 | 21 | 32 |
| 2020 | 30 | 30 |
| 2021 | 26 | 43 |
| 2022 | 15 | 38 |
| 2023 | 19 | 32 |
| 2024 | 17 | 36 |
| 2025 | 12 | 27 |
| 2026 | 16 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thrombus imaging aptamers and methods of using same4 Aug 2026US 12,697,401 B2Duke University
- Nucleic acid complexes for screening barcoded compounds28 Jul 2026US 12,692,491 B2Children's Medical Center Corporation
- Transcriptome In Vivo Analysis (TIVA) and Transcriptome In Situ Analysis (TISA)23 Jun 2026US 12,662,501 B2The Trustees of the University of Pennsylvania
- Method and composition for measurement of nitric oxide23 Jun 2026US 12,663,426 B2The University of Chicago
- Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications2 Jun 2026US 12,642,867 B2Bar-Ilan University
- Composition for improving intestinal health and function comprising milk-derived exosomes as active ingredient, and manufacturing method thereof27 Aug 2026US 2026/0248732 A1Dong-A St Co., Ltd.
- Thiomorpholino antisense oligonucleotides for the treatment of ptp1b related diseases13 Aug 2026US 2026/0234632 A1Murdoch University
- Targeting Lignums30 Jul 2026US 2026/0218176 A1Arrowhead Pharmaceuticals, Inc.
- Inhibition of polyomavirus replication2 Jul 2026US 2026/0185099 A1Academisch Ziekenhuis Leiden (H.O.D.N. Lumc)
- Downregulating trolls using novel antisense oligonucleotides to overcome resistance to chemotherapy7 May 2026US 2026/0125675 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
Most cited
By later US patents
- Antisense oligonucleotide modulation of multidrug resistance-associated protein841US 5,801,154 AIsis Pharmaceuticals, Inc. · 1998
- Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved663US 5,403,711 AUniversity of Iowa Research Foundation · 1995
- 2'modified nucleoside and nucleotide compounds599US 5,466,786 AGilead Sciences, Inc. · 1995
- Methods for blocking the expression of specifically targeted genes334US 5,491,133 AUniversity of Iowa Research Foundation · 1996
- 2' Modified Oligonucleotides273US 5,792,847 AGilead Sciences, Inc. · 1998